Topics

Mylan issues recall for anxiety drug Xanax over contamination fears

06:58 EDT 29 Oct 2019 | Pharmafile

Mylan has announced it has issued a recall of its anxiety therapy Xanax (alprazolam) over suspicions the drug could be contaminated with a “foreign substance” and pose a risk to patients.

The alert was made known via the FDA website and concerns the 0.5mg tablet formulation of the drug, made available throughout July and August this year in bottles of 500.

Image caption: 
Image credit: Dean812, https://www.flickr.com/photos/deanslife/1269477821

read more

Original Article: Mylan issues recall for anxiety drug Xanax over contamination fears

NEXT ARTICLE

More From BioPortfolio on "Mylan issues recall for anxiety drug Xanax over contamination fears"

Quick Search

Relevant Topics

Anxiety Disorders
Anxiety is caused by stress. It is a natural reaction, and is beneficial in helping us deal with tense situations and pressure. It is deterimental when is becomes an excessive, irrational dread of everyday situations. The most common types of anxiety di...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...